| scholarly article | Q13442814 |
| P50 | author | Ottavio Arancio | Q57733929 |
| Frank J. Gunn-Moore | Q77058386 | ||
| P2093 | author name string | Fang Fang | |
| Jun Yao | |||
| Shirley ShiDu Yan | |||
| Chaodong Wang | |||
| Heng Du | |||
| Doris Chen | |||
| John Xi Chen | |||
| Lan Guo | |||
| Lih-Fen Lue | |||
| David M Stern | |||
| Shiqiang Yan | |||
| P2860 | cites work | Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease | Q24294639 |
| Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP | Q24297496 | ||
| An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease | Q24319073 | ||
| Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model | Q28204241 | ||
| Endophilin I expression is increased in the brains of Alzheimer disease patients | Q28263217 | ||
| Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model | Q28301457 | ||
| In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis | Q28570309 | ||
| High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation | Q29616564 | ||
| Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease | Q30454431 | ||
| Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. | Q30470555 | ||
| The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome. | Q34148933 | ||
| Protein transduction technology | Q34534961 | ||
| Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. | Q34562025 | ||
| Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases | Q34976991 | ||
| Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence | Q35433892 | ||
| Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model | Q35831042 | ||
| Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment | Q35891905 | ||
| Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). | Q36135523 | ||
| Mitochondrial amyloid-beta peptide: pathogenesis or late-phase development? | Q36549405 | ||
| The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae | Q36856671 | ||
| Amyloid-beta-induced mitochondrial dysfunction | Q36942358 | ||
| Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer | Q37073826 | ||
| Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease | Q37321251 | ||
| Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease | Q37463481 | ||
| RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice | Q40251711 | ||
| Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression | Q40301497 | ||
| Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation | Q40850307 | ||
| Mitochondrial abnormalities in Alzheimer's disease. | Q43581697 | ||
| Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. | Q43623412 | ||
| Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. | Q43769073 | ||
| Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions | Q44193907 | ||
| ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction | Q45234437 | ||
| Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease | Q47714762 | ||
| ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease | Q47754186 | ||
| Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity | Q48304478 | ||
| Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. | Q48453834 | ||
| RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling | Q48894344 | ||
| A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. | Q52541271 | ||
| A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. | Q53341470 | ||
| Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal | Q77648460 | ||
| Alzheimer's APP mangles mitochondria | Q79334831 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 2313-2320 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease | |
| P478 | volume | 31 |
| Q34211127 | A mitochondrial etiology of Alzheimer and Parkinson disease |
| Q38933148 | Amyloid precursor protein processing and bioenergetics |
| Q34395478 | Amyloid-β peptide binds to cytochrome C oxidase subunit 1. |
| Q37647941 | Antioxidant gene therapy against neuronal cell death |
| Q90462496 | Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer's Disease Treatment |
| Q38472553 | Beta-amyloid oligomers: recent developments |
| Q35911424 | Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucoma |
| Q34199931 | Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria |
| Q37576151 | Epoxyeicosatrienoic acids pretreatment improves amyloid β-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes |
| Q34794864 | From a Cell's Viewpoint: Targeting Mitochondria in Alzheimer's disease |
| Q53116855 | Genome instability in Alzheimer disease. |
| Q36054716 | Ginsenoside Rg1 attenuates oligomeric Aβ(1-42)-induced mitochondrial dysfunction |
| Q37433859 | High Pressure-Induced mtDNA Alterations in Retinal Ganglion Cells and Subsequent Apoptosis. |
| Q48317299 | Hopeahainol A attenuates memory deficits by targeting β-amyloid in APP/PS1 transgenic mice |
| Q33850211 | Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction |
| Q35240665 | Identification of human presequence protease (hPreP) agonists for the treatment of Alzheimer's disease |
| Q37351380 | Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain |
| Q38703059 | In silico-designed novel non-peptidic ABAD LD hot spot mimetics reverse Aβ-induced mitochondrial impairments in vitro. |
| Q35999286 | Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model |
| Q46378939 | Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model |
| Q28478362 | Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol |
| Q93042503 | Interactions of 17β-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease |
| Q27324934 | Intracellular cleavage of amyloid β by a viral protease NIa prevents amyloid β-mediated cytotoxicity |
| Q50930159 | Intracellular ion channel CLIC1: involvement in microglia-mediated β-amyloid peptide(1-42) neurotoxicity. |
| Q36908481 | Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? |
| Q36456888 | Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease? |
| Q46784990 | Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model |
| Q47784287 | Mitochondria and Mitochondrial Cascades in Alzheimer's Disease |
| Q35898628 | Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease |
| Q38883083 | Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease |
| Q38932850 | Mitochondria, Cybrids, Aging, and Alzheimer's Disease |
| Q33608218 | Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation |
| Q48769729 | Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells |
| Q48284335 | Mitochondrial Perturbation in Alzheimer's Disease and Diabetes |
| Q36882858 | Mitochondrial aldehyde dehydrogenase-2 activation prevents β-amyloid-induced endothelial cell dysfunction and restores angiogenesis |
| Q34299120 | Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer's disease |
| Q27009475 | Mitochondrial dysfunction: different routes to Alzheimer's disease therapy |
| Q26824822 | Mitochondrial function and dysfunction: an update |
| Q57170869 | Mitochondrial permeability transition pore: a potential drug target for neurodegeneration |
| Q35579334 | Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease |
| Q49015269 | Mitochondrial β-amyloid in Alzheimer's disease. |
| Q42190615 | Molecular docking of fisetin with AD associated AChE, ABAD and BACE1 proteins |
| Q53143766 | Morphology-Specific Inhibition of β-Amyloid Aggregates by 17β-Hydroxysteroid Dehydrogenase Type 10. |
| Q59393040 | Neuronal Preconditioning Requires the Mitophagic Activity of C-terminus of HSC70-Interacting Protein |
| Q51471465 | Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats. |
| Q61135270 | Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer's disease |
| Q30574513 | PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease |
| Q47372795 | Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases |
| Q34623948 | Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder. |
| Q39145449 | Recent Progress in Alzheimer's Disease Research, Part 1: Pathology |
| Q33556068 | Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment |
| Q26864926 | Reevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle Model |
| Q40984233 | Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers |
| Q36806595 | Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease |
| Q35898625 | Synaptic mitochondrial pathology in Alzheimer's disease |
| Q35738734 | Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease |
| Q35800000 | The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease |
| Q26744834 | The Rationale for Insulin Therapy in Alzheimer's Disease |
| Q34766658 | The amyloid-β-SDR5C1(ABAD) interaction does not mediate a specific inhibition of mitochondrial RNase P. |
| Q33936364 | The novel amyloid-beta peptide aptamer inhibits intracellular amyloid-beta peptide toxicity |
| Q39627759 | Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction. Hypothetical role of the adapter protein ECSIT in familial and sporadic Alzheimer's disease pathogenesis |
| Q35911798 | Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration |
| Q34128067 | rAAV/ABAD-DP-6His attenuates oxidative stress-induced injury of PC12 cells |
Search more.